PharmSource – Bio/Pharma CapEx Trends – 2019 Edition

Research By Markets adds Market Research Report - PharmSource – Bio/Pharma CapEx Trends – 2019 Edition

For detailed information:

PharmSource – Bio/Pharma CapEx Trends – 2019 Edition


Captive capacity remains the largest impediment to faster growth of the contract manufacturing and development industry. Based on recent capital expenditure trends, it’s clear that bio/pharma companies would rather “make than buy.”

This expert trend report is a comprehensive look at the capital expenditure of pharma companies on manufacturing facilities/capabilities, including analysis of market cap patterns, headquarter geography and manufacturing services being invested in. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.


– This 32-page report gives an important expert quantitative analysis on the capital expenditure. Findings are based on the our Financial Analytics tool, financials have been analyzed for 1,345 pharma companies. The 5 tables and 11 figures throughout the report illustrate major points and trends. This report is required reading for –
– – CMO executives and strategic decision-makers: improves understanding of the dose CMO industry and a critical input for strategic planning efforts.
– – Sourcing and procurement executives in bio/pharmaceutical companies: improving understanding of crucial components of the supply base that will provide insights for supplier selection and management.
– – Suppliers of capital components

Reasons to buy

– How are trends in CapEx related to company revenue?
– What has been the CapEx growth trends between 2014-2018?
– How do trends in CapEx vary by company market cap?
– How do CapEx trend change by company HQ location?
– What is the CapEx for leading public CDMOs?
– Which pharma companies have the highest number of CapEx projects?
– What CapEx projects were completed 2016-2018 or have a projected completion for 2019-2025 and which manufacturing services and facility locations are involved?

Companies Mentioned:
Abbvie Inc
Alexion Pharmaceuticals Inc
Amgen Inc
Astellas Pharma Inc
AstraZeneca Plc
Bachem Holding AG
Bayer AG
Biogen Inc
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co
Cambrex Corp
Catalent Inc
Chugai Pharmaceutical Co Ltd
Daiichi Sankyo Co Ltd
Dottikon ES Holding AG
Eli Lilly and Co
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
Johnson & Johnson
Lonza Group Ltd
Merck & Co Inc
Novartis AG
Novo Nordisk AS
Otsuka Holdings Co Ltd
Pfizer Inc
Recipharm AB
Siegfried Holding AG
Sumitomo Dainippon Pharma Co Ltd
Syngene International Ltd
Takeda Pharmaceutical Co Ltd
Teva Pharmaceutical Industries Ltd

For queries regarding this report:

Contact Us:
Sales Desk

Follow us on Social Media:

Ritesh Tiwari is the Founder of Research By Markets, a leading Market Research Reports Reseller trusted by Fortune listed companies for their requirements of Syndicated and Custom Market Research Reports. Ritesh has an overall experience of 18+ years in Recruitments, Sales and Operations. He has been associated with the Market Research industry for the past 7 years. He is an avid foodie as well as a huge football fan being a supporter of Manchester United (EPL) and FC Barcelona (La Liga). Get in touch with him via *Market Research News is a part of Research By Markets.